These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 17640161

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apc min/+ mice.
    Lawrance AK, Deng L, Rozen R.
    Gut; 2009 Jun; 58(6):805-11. PubMed ID: 19174418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL, Schut HA, Nesland JM, Tanaka K, Alexander J.
    Mutat Res; 2006 Dec 10; 611(1-2):71-82. PubMed ID: 16962818
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
    Dai WB, Ren ZP, Chen WL, DU J, Shi Z, Tang DY.
    Ai Zheng; 2007 Sep 10; 26(9):963-6. PubMed ID: 17927853
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K, Baudino TA.
    Mol Cancer Res; 2007 Dec 10; 5(12):1296-303. PubMed ID: 18171987
    [Abstract] [Full Text] [Related]

  • 9. Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer.
    Javid SH, Moran AE, Carothers AM, Redston M, Bertagnolli MM.
    Carcinogenesis; 2005 Mar 10; 26(3):587-95. PubMed ID: 15579483
    [Abstract] [Full Text] [Related]

  • 10. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
    Schmelz EM, Roberts PC, Kustin EM, Lemonnier LA, Sullards MC, Dillehay DL, Merrill AH.
    Cancer Res; 2001 Sep 15; 61(18):6723-9. PubMed ID: 11559543
    [Abstract] [Full Text] [Related]

  • 11. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
    Tomita H, Yamada Y, Oyama T, Hata K, Hirose Y, Hara A, Kunisada T, Sugiyama Y, Adachi Y, Linhart H, Mori H.
    Cancer Res; 2007 May 01; 67(9):4079-87. PubMed ID: 17483318
    [Abstract] [Full Text] [Related]

  • 12. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q, Ishikawa TO, Oshima M, Taketo MM.
    Cancer Res; 2005 Oct 01; 65(19):8622-7. PubMed ID: 16204028
    [Abstract] [Full Text] [Related]

  • 13. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
    Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, Papagni S, Guido R, Maiorano E, Ingravallo G, Comelli MC, Francavilla A, Di Leo A.
    Carcinogenesis; 2010 Feb 01; 31(2):269-74. PubMed ID: 19945967
    [Abstract] [Full Text] [Related]

  • 14. Berries as chemopreventive dietary constituents--a mechanistic approach with the ApcMin/+ mouse.
    Mutanen M, Pajari AM, Paivarinta E, Misikangas M, Rajakangas J, Marttinen M, Oikarinen S.
    Asia Pac J Clin Nutr; 2008 Feb 01; 17 Suppl 1():123-5. PubMed ID: 18296318
    [Abstract] [Full Text] [Related]

  • 15. Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets.
    Sun X, Zemel MB.
    Int J Obes (Lond); 2006 Sep 01; 30(9):1341-6. PubMed ID: 16520808
    [Abstract] [Full Text] [Related]

  • 16. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL, Kettunen AS, Rautonen NE.
    Cancer Res; 2003 Aug 15; 63(16):5136-42. PubMed ID: 12941845
    [Abstract] [Full Text] [Related]

  • 17. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ, Kantoci D, Murray ED, Quiggle DD, Leipold DD, Gibson KM, McCracken JD.
    Cancer Res; 1997 Oct 01; 57(19):4316-24. PubMed ID: 9331093
    [Abstract] [Full Text] [Related]

  • 18. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis.
    Weyant MJ, Carothers AM, Mahmoud NN, Bradlow HL, Remotti H, Bilinski RT, Bertagnolli MM.
    Cancer Res; 2001 Mar 15; 61(6):2547-51. PubMed ID: 11289129
    [Abstract] [Full Text] [Related]

  • 19. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H, Ito Y.
    Cancer Cell; 2008 Sep 09; 14(3):226-37. PubMed ID: 18772112
    [Abstract] [Full Text] [Related]

  • 20. Plant stanols induce intestinal tumor formation by up-regulating Wnt and EGFR signaling in Apc Min mice.
    Marttinen M, Päivärinta E, Storvik M, Huikko L, Luoma-Halkola H, Piironen V, Pajari AM, Mutanen M.
    J Nutr Biochem; 2013 Jan 09; 24(1):343-52. PubMed ID: 22981369
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.